Get the Stockscreener App
4.39
0.90%
-0.04
After Hours:
4.39
Goodrx Holdings Inc stock is traded at $4.39, with a volume of 1.20M.
It is down -0.90% in the last 24 hours and up +10.86% over the past month.
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
See More
Previous Close:
$4.43
Open:
$4.42
24h Volume:
1.20M
Relative Volume:
0.83
Market Cap:
$1.47B
Revenue:
$775.09M
Net Income/Loss:
$-58.68M
P/E Ratio:
-33.11
EPS:
-0.1326
Net Cash Flow:
$64.06M
1W Performance:
-3.30%
1M Performance:
+10.86%
6M Performance:
-1.57%
1Y Performance:
-47.68%
1-Day Range:
$4.375
$4.50
1-Week Range:
$4.33
$4.67
52-Week Range:
$3.675
$9.2599
Goodrx Holdings Inc Stock (GDRX) Company Profile
Name
Goodrx Holdings Inc
Sector
Industry
Phone
(855) 268-2822
Address
2701 OLYMPIC BOULEVARD, SANTA MONICA
Compare GDRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GDRX
Goodrx Holdings Inc
|
4.39 | 1.47B | 775.09M | -58.68M | 64.06M | -0.1326 |
|
VEEV
Veeva Systems Inc
|
281.89 | 46.30B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
70.11 | 11.59B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
58.51 | 10.91B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
100.01 | 9.27B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
38.33 | 7.03B | 906.14M | -52.62M | 89.62M | -0.3621 |
Goodrx Holdings Inc Stock (GDRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Aug-09-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| May-23-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| May-16-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Apr-10-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-25-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-01-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-02-24 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-10-23 | Upgrade | DA Davidson | Neutral → Buy |
| Jul-31-23 | Upgrade | TD Cowen | Market Perform → Outperform |
| Dec-01-22 | Initiated | Citigroup | Buy |
| Nov-04-22 | Upgrade | JP Morgan | Underweight → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-12-22 | Initiated | DA Davidson | Neutral |
| Jun-10-22 | Downgrade | Goldman | Buy → Neutral |
| Jun-06-22 | Resumed | BofA Securities | Buy |
| Jun-01-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-10-22 | Downgrade | Evercore ISI | Outperform → In-line |
| May-10-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| May-10-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-10-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-11-22 | Initiated | Wells Fargo | Equal Weight |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Neutral |
| Mar-15-22 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-01-22 | Reiterated | Barclays | Overweight |
| Mar-01-22 | Reiterated | BofA Securities | Neutral |
| Mar-01-22 | Downgrade | Cowen | Outperform → Market Perform |
| Mar-01-22 | Downgrade | Credit Suisse | Outperform → Neutral |
| Mar-01-22 | Reiterated | Evercore ISI | Outperform |
| Mar-01-22 | Reiterated | Goldman | Buy |
| Mar-01-22 | Reiterated | JP Morgan | Underweight |
| Mar-01-22 | Reiterated | RBC Capital Mkts | Outperform |
| Mar-01-22 | Reiterated | SVB Leerink | Outperform |
| Jan-07-22 | Initiated | Goldman | Buy |
| Dec-21-21 | Initiated | Stephens | Overweight |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Aug-31-21 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-13-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-28-21 | Initiated | Robert W. Baird | Neutral |
| Apr-06-21 | Resumed | Evercore ISI | Outperform |
| Jan-25-21 | Initiated | Guggenheim | Buy |
| Nov-19-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-18-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-19-20 | Initiated | Barclays | Equal Weight |
| Oct-19-20 | Initiated | BofA Securities | Neutral |
| Oct-19-20 | Initiated | Citigroup | Buy |
| Oct-19-20 | Initiated | Cowen | Outperform |
| Oct-19-20 | Initiated | Credit Suisse | Outperform |
| Oct-19-20 | Initiated | Deutsche Bank | Hold |
| Oct-19-20 | Initiated | Goldman | Neutral |
| Oct-19-20 | Initiated | JP Morgan | Neutral |
| Oct-19-20 | Initiated | Morgan Stanley | Overweight |
| Oct-19-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Oct-19-20 | Initiated | SVB Leerink | Outperform |
| Oct-19-20 | Initiated | UBS | Buy |
View All
Goodrx Holdings Inc Stock (GDRX) Latest News
GoodRx (GDRX) Launches a New Subscription Service for Erectile Dysfunction Treatment - Insider Monkey
GoodRx launches new subscription service focused on erectile dysfunction treatments - MSN
High Growth Tech Stocks In The US To Watch This June 2025 - simplywall.st
GoodRx (GDRX) Expands Services with New Subscription for ED Trea - GuruFocus
GoodRx (GDRX) Expands Services with New Subscription for ED Treatment | GDRX Stock News - GuruFocus
GoodRx (GDRX) Shares Rise with Launch of Erectile Dysfunction Subscription Service - GuruFocus
GoodRx stock gains on new subscription service (GDRX:NASDAQ) - Seeking Alpha
GoodRx (GDRX) Introduces Subscription Service for ED Treatment | - GuruFocus
GoodRx (GDRX) Introduces Subscription Service for ED Treatment | GDRX Stock News - GuruFocus
GoodRx Launches New Erectile Dysfunction Subscription Service to Simplify Access and Eliminate Treatment Barriers - marketscreener.com
GoodRx (GDRX): Buy, Sell, or Hold Post Q1 Earnings? - Yahoo Finance
GoodRx Launches Community Link to Offer Independent Pharmacies C - GuruFocus
GoodRx Launches Community Link to Offer Independent Pharmacies Cost-Plus Pricing | GDRX Stock News - GuruFocus
GoodRx Launches Community Link to Offer Independent Pharmacies Cost-Plus Pricing - marketscreener.com
GoodRx Disrupts Pharmacy Market with New Cost-Plus Pricing Model for Independent Stores - Stock Titan
GoodRx Launches Community Link to Offer Independent Pharmacies Cost-Plus Pricing – Company Announcement - Financial Times
Jim Cramer Holds Back on GoodRx (GDRX) - MSN
GoodRx: Stabilizing Revenue Amid Healthy Profit Gains - Seeking Alpha
GoodRx Launches Free Developer Tool That Slashes Testing Time and Infrastructure Costs - Stock Titan
GoodRx Holdings Holds Annual Stockholder Meeting - TipRanks
29,380 Shares in GoodRx Holdings, Inc. (NASDAQ:GDRX) Acquired by Deutsche Bank AG - Defense World
AbCellera Biologics And 2 Other Promising Penny Stocks To Watch - simplywall.st
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Lowers Stake in GoodRx Holdings, Inc. (NASDAQ:GDRX) - Defense World
Head-To-Head Contrast: GoodRx (NASDAQ:GDRX) & Yext (NYSE:YEXT) - Defense World
BNP Paribas Financial Markets Purchases Shares of 39,285 GoodRx Holdings, Inc. (NASDAQ:GDRX) - Defense World
Lazard Asset Management LLC Sells 51,337 Shares of GoodRx Holdings, Inc. (NASDAQ:GDRX) - Defense World
GoodRx Holdings, Inc. (NASDAQ:GDRX) Shares Purchased by Northern Trust Corp - Defense World
GoodRx’s SWOT analysis: prescription savings firm faces pharmacy headwinds - Investing.com
GoodRx to Launch Direct Contracting for Independent Community Pharmacies - marketscreener.com
GoodRx Disrupts Pharmacy Pricing: New Platform Gives Independent Pharmacies Direct Control Over Margins - Stock Titan
GoodRx Holdings, Inc. (NASDAQ:GDRX) Given Average Rating of “Moderate Buy” by Analysts - Defense World
GoodRx Offers Value Proposition As Pharmacy Costs Shifts To Consumers: Analyst - AOL.com
KeyBanc maintains GoodRx stock Overweight with $6 target By Investing.com - Investing.com Nigeria
KeyBanc maintains GoodRx stock Overweight with $6 target - Investing.com
KeyBanc on GoodRx Holdings Inc. (GDRX): 'Attractive Valuation as We Await Continued Execution' - StreetInsider
Demystifying GoodRx Holdings: Insights From 5 Analyst Reviews - Benzinga
UBS Adjusts Price Target for GoodRx (GDRX) Amid Neutral Rating | - GuruFocus
GoodRx Holdings (GDRX) Price Target Lowered by UBS | GDRX Stock News - GuruFocus
The Zacks Analyst Blog Highlights Sprouts Farmers Market, DexCom, Hims & Hers Health, United Natural Foods and GoodRx - TradingView
UBS Adjusts Price Target for GoodRx (GDRX) Amid Neutral Rating | GDRX Stock News - GuruFocus
UBS Adjusts Price Target on GoodRx Holdings to $5.25 From $6, Maintains Neutral Rating - marketscreener.com
Buy 5 Health and Fitness Stocks to Enhance Your Portfolio Returns - TradingView
The Goldman Sachs Group Cuts GoodRx (NASDAQ:GDRX) Price Target to $5.00 - Defense World
Dimensional Fund Advisors LP Raises Stake in GoodRx Holdings, Inc. (NASDAQ:GDRX) - Defense World
Wells Fargo & Company MN Sells 81,454 Shares of GoodRx Holdings, Inc. (NASDAQ:GDRX) - Defense World
GoodRx Holdings First Quarter 2025 Earnings: EPS Misses Expectations - Yahoo Finance
GoodRx Holdings, Inc. (NASDAQ:GDRX) Q1 2025 Earnings Call Transcript - Insider Monkey
GoodRx Holdings (GDRX) Price Target Lowered by Goldman Sachs | G - GuruFocus
Envestnet Asset Management Inc. Takes $84,000 Position in GoodRx Holdings, Inc. (NASDAQ:GDRX) - Defense World
GoodRx Holdings Inc (GDRX) Q1 2025 Earnings Call Highlights: Revenue Growth and Strategic ... - Yahoo Finance
GoodRx (NASDAQ:GDRX) Trading Up 11.9% on Strong Earnings - Defense World
Goodrx Holdings Inc Stock (GDRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.22%
4.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):